openPR Logo
Press release

Anaplastic Oligoastrocytoma Market to Rear Excessive Growth During 2016-2024

07-10-2017 02:48 PM CET | Health & Medicine

Press release from: Persistence Market Research

Anaplastic Oligoastrocytoma Market to Rear Excessive Growth

Oligoastrocytomas is a part of a group of brain tumor called “gliomas”. Glioma tumor is originated in the brain or spine. Oligoastrocytomas contains both astrocytoma cells and oligodendroglioma. About 2.3% of the brain tumors reported are diagnosed as oligoastrocytomas. Oligoastrocytomas is divided into two parts, low grade and anaplastic.

Get access to full summary @: http://www.persistencemarketresearch.com/market-research/anaplastic-oligoastrocytoma-market.asp

According to the WHO grading system, anaplastic oligoastrocytomas are usually identify as grade 1 and grade 2 but sometimes they appear to be grade 4. Anaplastic oligoastrocytomas can be characterized by high cellularity, conspicuous cytologic atypism, microvascular proliferation, mitotic activity and necrosis. Patients suffering from this condition show symptoms like headache, seizure and speech or motor changes. According to the American Brain Cancer Association, clinical trials for the treatment of this tumor are in process to minimize the recurrence rate of anaplastic oligoastocytoma caused after the surgical removal of tumor or chemotherapy and radiation therapy session.

Anaplastic oligoastrocytomas market is offers potential opportunities to cancer care industry. Factors contributing the growth of anaplastic oligoastrocytomas market are rising geriatric population, increasing incidence of anaplastic oligoastrocytomas and increasing pace of clinical trials for novel drug development. Moreover factors such as advancement in technology and innovations in diangositc techniques is expected to drive the growth of anaplastic oligoastrocytoma market over the forecast period. However, lack of specific treatment and critical diagnosis of anaplastic oligoastrocytoma is the major challenge for anaplastic oligoastrocytomas market.

A sample of this report is available upon request @ www.persistencemarketresearch.com/samples/10502

Basically the treatment of anaplastic oligoastrocytoma depends on the size of the tumor. The treatment is processed by surgery to remove the tumor. In order to eliminate the cancerous cells, the combinational therapies such as chemotherapy or radiation therapy are used as effective treatment for anaplastic oligoastrocytoma.

Oligoastrocytomas is most common in adults and generally occurs at the age of 35–50. Generally these type of tumors are found in both the genders. Children of age 0-14 are often diagnosed with oligoastrocytomas and these tumors comprises of only three percent of primary brain tumors. Factors such as increasing demand for treatment therapies for anaplastic oligoastrocytoma, increasing prevalence of anaplastic oligoastrocytoma in emerging economies are expected provide traction to the growth of anaplastic oligoastrocytoma over the forecast period (2016-2026)

On the basis of region presence, anaplastic oligoastrocytoma market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North America and Europe market are at maturity level for clinical research of treatment for anaplastic oligoastrocytomas. Markets of Asia-Pacific region have also shown keen interest in clinical trials of this tumor and are showing growth at faster pace, due to increasing incidence of anaplastic oligoastrocytoma.

To view TOC of this report is available upon request @ www.persistencemarketresearch.com/toc/10502

Following are the companies and institutions which are involved in clinical trials of treatment for anaplastic oligoastocytomas are Tocagen, Inc., Shandong Lanjin Pharmaceuticals Co. Ltd, Keryx Biopharmaceuticals, Inc., Biogen Idec, Inc., Insys Therapeutics, Inc, Rush University Medical Center and University of California, San Diego.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anaplastic Oligoastrocytoma Market to Rear Excessive Growth During 2016-2024 here

News-ID: 617294 • Views: 154

More Releases from Persistence Market Research

Connected Homes Market to Reach a Valuation Higher than US$ 138 Bn by 2026
Connected Homes Market 2021-2026 New Study Reports " Connected Homes Market 2021 Global Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on PersistenceMarketResearch. Report Details: This report provides in depth study of “Connected Homes Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Connected Homes Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling,
Iot Market 2021: Global Projection by Key Players – IBM Corporation, Microsoft …
Iot Market 2021-2026 New Study Reports " Iot Market 2021 Global Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on PersistenceMarketResearch. Report Details: This report provides in depth study of “Iot Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Iot Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the
Mobile Advertising Market 2021 Expected to reach US$ 120 Billion with 18.8% CAGR …
Mobile Advertising Market 2021-2025 New Study Reports " Mobile Advertising Market 2021 Global Opportunities, Challenges, Strategies and Forecasts 2025" has been Added on PersistenceMarketResearch. Report Details: This report provides in depth study of “Mobile Advertising Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Mobile Advertising Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling,
Building Automation Systems Market 2021 Expected to reach 248 Bn US$ with 11.3% …
Building Automation Systems Market 2021-2031 New Study Reports " Building Automation Systems Market 2021 Global Opportunities, Challenges, Strategies and Forecasts 2031" has been Added on PersistenceMarketResearch. Report Details: This report provides in depth study of “Building Automation Systems Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Building Automation Systems Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an

All 5 Releases


More Releases for Anaplastic

Anaplastic Astrocytoma Market Development, Trends, Segmentations Analysis
Anaplastic astrocytoma is a very rare type of malignant brain tumor affecting human at all ages. As this tumor develops from astrocytes, the star-shaped brain cells it is termed as astrocytoma. The astrocytes along with other cells protect nerve cells in the brain and spinal cord by surrounding them. All these protective cells are collectively termed as glial cells. World Health Organization (WHO) graded these tumors on a scale from
Anaplastic Oligoastrocytoma Therapeutics Pipeline Review 2018
Anaplastic oligoastrocytoma is a type of brain tumour in which certain brain cells such as oligodendrocytes and astrocytes, rapidly increase in number and form a mass. The disease is also called mixed glioma because it involves two types of cells. Anaplastic oligoastrocytoma generally occurs in the cerebrum region. Some of the symptoms of anaplastic oligoastrocytoma include seizures, headache and change in personality. The disease can be treated by surgical methods
Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insights 2017
The “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of ALK drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential ALK inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent,
Anaplastic Oligoastrocytoma Therapeutics Pipeline Analysis - Clinical Trials , R …
Anaplastic oligoastrocytoma is a type of brain tumour in which certain brain cells such as oligodendrocytes and astrocytes, rapidly increase in number and form a mass. The disease is also called mixed glioma because it involves two types of cells. Anaplastic oligoastrocytoma generally occurs in the cerebrum region. Some of the symptoms of anaplastic oligoastrocytoma include seizures, headache and change in personality. Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/anaplastic-oligoastrocytoma-therapeutics-pipeline-analysis
Anaplastic Oligoastrocytoma Market to Register Substantial Expansion by 2024
Oligoastrocytomas is a part of a group of brain tumor called “gliomas”. Glioma tumor is originated in the brain or spine. Oligoastrocytomas contains both astrocytoma cells and oligodendroglioma. About 2.3% of the brain tumors reported are diagnosed as oligoastrocytomas. Oligoastrocytomas is divided into two parts, low grade and anaplastic. According to the WHO grading system, anaplastic oligoastrocytomas are usually identify as grade 1 and grade 2 but sometimes they appear to
Growth Anaplastic Oligoastrocytoma Market : 2016 - 2024
Oligoastrocytomas is a part of a group of brain tumor called “gliomas”. Glioma tumor is originated in the brain or spine. Oligoastrocytomas contains both astrocytoma cells and oligodendroglioma. About 2.3% of the brain tumors reported are diagnosed as oligoastrocytomas. Oligoastrocytomas is divided into two parts, low grade and anaplastic. According to the WHO grading system, anaplastic oligoastrocytomas are usually identify as grade 1 and grade 2 but sometimes they appear